FIELD: medicine.
SUBSTANCE: invention claims application of naphthalene derivatives: ethylene blue, anthracene, acridine orange, acriflavine, toluidine blue, violamine R, green sulfonic acid, as cancer cell growth inhibitor for treatment of oncology diseases. Application involves administration of medicine up to three times per day by one-time dosage of 0.1 mg to 2 g in the form of solution or inhalation or water solution. Simultaneously medicine is administered rectally or intravenously in the form of 1-5% ointment or suppository. Tumour and metastasis regression is achieved under effect of indicated compounds for osteosarcoma with metastases in lungs, kidney cancer, ovary carcinoma, squamous cell carcinoma, prostate or rectum adenocarcinoma (with metastases to liver), lymphoma, hepatoma, glioblastoma etc. During therapy tumour and metastases disappeared, blood and urine analyses and patient's weight returned to normal. No recurrences have been registered in 4 years.
EFFECT: obtaining medicine inhibiting cancer cell growth for oncology disease treatment.
10 cl, 3 dwg, 17 ex, 6 tbl
